|
?:authorAffiliation
|
-
[\'Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.\', \'Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.\', \'Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway; s.e.pischke@medisin.uio.no.\', \'Division of Emergencies and Critical Care, Oslo University Hospital, 0424 Oslo, Norway.\', \'Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.\', \'Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway.\', \'Department of Acute Medicine, Oslo University Hospital, 0424 Oslo, Norway.\', \'Department of Pharmacology, University of Oslo, 0315 Oslo, Norway.\', \'Department of Ophthalmology, Oslo University Hospital, 0424 Oslo, Norway.\', \'Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway.\', \'Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway.\', \'Department of Internal Medicine, Vestre Viken Hospital Trust, 3004 Drammen, Norway.\', \'Department of Clinical Science, Faculty of Medicine, University of Bergen, 5007 Bergen, Norway.\', \'Faculty of Health Sciences, K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, 9037 Tromsø, Norway.\', \'ImmunoLingo Convergence Centre, University of Oslo, 0315 Oslo, Norway.\', \'Research Laboratory, Nordland Hospital Bodø, 8092 Bodø, Norway.\', \'Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, 7491 Trondheim, Norway.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}